Literature DB >> 15617743

Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2.

Muzahir H Tayebjee1, Gregory Y H Lip, Andrew D Blann, Robert J Macfadyen.   

Abstract

BACKGROUND: Circulating metalloproteinases (MMP) and their inhibitors (TIMP) are indices of vascular and cardiac tissue matrix turnover. However, the temporal changes and relationship of these parameters to age, gender, ethnicity and exercise have been poorly defined. We therefore studied these aspects on plasma levels of MMP-2 and -9 and TIMP-1 and -2, as the major metalloproteinases (and their inhibitors) implicated in pathophysiology of vascular disease.
METHODS: Venous citrated blood was collected from 93 normal healthy volunteers from four ethnic groups (Afro-Caribbean, South Asian, Caucasian and Far Eastern) for a cross-sectional study. In addition, 20 separate healthy volunteers were studied during supine rest, before and immediately following peak treadmill stress using a Bruce protocol. MMP-2 and -9 and TIMP-1 and -2 were all measured by ELISA.
RESULTS: There was a categorical distribution of MMP-2 concentration with individual subjects showing high levels, yet others being undetectable, although these changes were unrelated to age, gender or ethnicity. TIMP-1 and -2 showed a modest negative correlation with age (r=-0.251, p=0.015; r=-0.254, p=0.014). There was a positive correlation between MMP-2 and TIMP-2 (r=0.399, p<0.001), MMP-9 and TIMP-1 (r=0.45, p<0.001) and between TIMP-1 and TIMP-2 (r=0.275, p=0.008). When adjusted for age and gender, there were no significant differences in MMP-2 and TIMP-1 and -2 between the four ethnic groups. MMP-9 was significantly lower in the Far Eastern group compared to the other three ethnic groups (p=0.012). Only TIMP-1 (p=0.042) and TIMP-2 (p=0.024) were significantly altered after exercise.
CONCLUSION: Age and exercise both have modest effects on circulating concentrations of TIMP-1 and-2. MMP-9 appears lower in individuals of Far Eastern/Chinese origin regardless of age or gender. The positive association between MMPs and TIMPs suggests that in healthy individuals, enzyme activity may be regulated by this interaction. The reasons for the categorical distribution of MMP-2 remain unclear but this would be important in any studies designed to use circulating MMPs as a surrogate for tissue MMPs around clinical events, such as myocardial infarction or in response to therapies affecting extracellular matrix composition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15617743     DOI: 10.1016/j.thromres.2004.08.023

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  28 in total

1.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

Review 2.  The Aging Heart.

Authors:  Ying Ann Chiao; Peter S Rabinovitch
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-01       Impact factor: 6.915

3.  Differential effect of 17-beta-estradiol on smooth muscle cell and aortic explant MMP2.

Authors:  Derek T Woodrum; John W Ford; Brenda S Cho; Kevin K Hannawa; James C Stanley; Peter K Henke; Gilbert R Upchurch
Journal:  J Surg Res       Date:  2008-08-15       Impact factor: 2.192

4.  Increase in IL-6, TNF-α, and MMP-9, but not sICAM-1, concentrations depends on exercise duration.

Authors:  Dace Reihmane; Antra Jurka; Peteris Tretjakovs; Flemming Dela
Journal:  Eur J Appl Physiol       Date:  2012-09-19       Impact factor: 3.078

5.  Circulating matrix metalloproteinases and their tissue inhibitors as markers for ethnic variation in pelvic floor tissue integrity.

Authors:  Diaa E E Rizk; Ghada Al-Kafaji; Ahmed A Jaradat; Diab Al-Tayab; Moiz Bakhiet; Stefano Salvatore
Journal:  Biomed Rep       Date:  2018-07-12

6.  Inflammageing assessed by MMP9 in normal Japanese individuals and the patients with Werner syndrome.

Authors:  Makoto Goto; Junji Chiba; Masaaki Matsuura; Sachiko Iwaki-Egawa; Yasuhiro Watanabe
Journal:  Intractable Rare Dis Res       Date:  2016-05

7.  Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs).

Authors:  D Dirk Bonnema; Carson S Webb; Weems R Pennington; Robert E Stroud; Amy E Leonardi; Leslie L Clark; Catherine D McClure; Laura Finklea; Francis G Spinale; Michael R Zile
Journal:  J Card Fail       Date:  2007-09       Impact factor: 5.712

8.  Evaluation of metalloproteinases 2 and 9 and their inhibitors in physiologic and pre-eclamptic pregnancy.

Authors:  Martina Montagnana; Giuseppe Lippi; Alessandro Albiero; Silvia Scevarolli; Gian Luca Salvagno; Massimo Franchi; Gian Cesare Guidi
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 9.  Matrix metalloproteinases and peripheral arterial disease.

Authors:  Chiara Busti; Emanuela Falcinelli; Stefania Momi; Paolo Gresele
Journal:  Intern Emerg Med       Date:  2009-07-21       Impact factor: 3.397

10.  Effects of exercise training on the matrix metalloprotease response to acute exercise.

Authors:  Maria L Urso; Joseph R Pierce; Joseph A Alemany; Everett A Harman; Bradley C Nindl
Journal:  Eur J Appl Physiol       Date:  2009-04-29       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.